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Available online 7 March 2008Progesterone-induced Xenopus laevis oocyte maturation is mediated via a plasma membrane-bound receptor
and does not require gene transcription. Evidence from several species suggests that the relevant
progesterone receptor is a G-protein coupled receptor (GPCR) and that a second receptor–GPR3 and/or
GPR12 in mammals–tonically opposes the progesterone receptor. We have cloned a novel X. laevis GPCR,
GPRx, which may play a similar role to GPR3/GPR12 in amphibians and ﬁshes. GPRx is related to but distinct
from GPR3, GPR6, and GPR12; GPRx orthologs are present in Xenopus tropicalis and Danio rerio, but apparently
not in birds or mammals. X. laevis GPRx is mainly expressed in brain, ovary, and testis. The GPRx mRNA
increases during oogenesis, persists during oocyte maturation and early embryogenesis, and then falls after
the midblastula transition. Microinjection of GPRx mRNA increases the concentration of cAMP in oocytes and
causes the oocytes to fail to respond to progesterone, and this block is reversed by co-injecting GPRx with
morpholino oligonucleotides. Morpholino injections did not cause spontaneousmaturation of oocytes, but did
accelerate progesterone-induced maturation. Thus, GPRx contributes to the maintenance of G2-arrest in
immature X. laevis oocytes.










cAMPIntroductionFully grown, immature oocytes spontaneously arrest during the
ﬁrst meiotic prophase. Oocytes are released from this arrest and
develop into fertilizable eggs through a process termed meiotic
maturation. In vertebrate oocytes, the hallmarks of meiotic matura-
tion include the resumption of meiosis I, which includes germinal
vesicle breakdown (GVBD), chromosome condensation and spindle
formation; the completion of meiosis I, with the extrusion of the ﬁrst
polar body; a brief period between meiosis I and meiosis II during
which S-phase is blocked; and ﬁnally arrest in metaphase II because of
cytostatic factor (CSF) activity. Meiosis II is completed after a mature
oocyte is ovulated, at which point it becomes an egg, and capable of
being fertilized (Ferrell, 1999).
In Xenopus laevis oocytes, maturation is triggered by the ovarian
hormone progesterone. Progesterone acts through a non-classical
plasma membrane receptor (Karaiskou et al., 2001; Maller, 1985) and
causes a transient decrease in cAMP levels. This decrease in cAMP
appears to be a key early event (Cork et al., 1990; Maller et al., 1979b);
maturation can be blocked by an increased level of cAMP or by
activation of PKA (Daar et al., 1993; Huchon et al., 1981; Masui and
Markert, 1971), and maturation can be induced in the absence ofell).
l rights reserved.progesterone by expression of a cAMP phosphodiesterase (Andersen
et al., 1998). The decrease in cAMP is generally thought to initiate
maturation, but it may also affect the positive feedback loops that
ultimately bring about full activation of p42MAPK and CDK1 just prior
to GVBD (Duckworth et al., 2002).
Several groups have demonstrated that the classical progesterone
receptor has non-genomic effects that contribute to oocyte matura-
tion (Bagowski et al., 2001; Bayaa et al., 2000; Boonyaratanakornkit et
al., 2001; Liu et al., 2005; Tian et al., 2000). In addition, progestins can
be metabolized to androgens in oocytes (Lutz et al., 2001), and the
classical androgen receptor may contribute non-genomic effects to
oocyte maturation (Evaul et al., 2007; Hammes, 2004; Lutz et al.,
2001). However, recent evidence suggests that one or more G-protein
coupled receptors also play critical roles in the process. The main
candidate for the relevant progesterone receptor is XmPRβ (Josefsberg
Ben-Yehoshua et al., 2007), a X. laevis homolog of a membrane-bound
progestin receptor originally cloned from ﬁsh oocytes (Zhu et al.,
2003). XmPRβ and its close relatives constitute a subgroup of the
PAQR proteins, a family of evolutionarily ancient seven-transmem-
brane proteins only distantly related to the other members of the
GPCR superfamily (like the well-studied rhodopsin-like GPCRs, the
Frizzled-like seven-transmembrane proteins, and so on) (Fredriksson
et al., 2003; Tang et al., 2005; Thomas et al., 2006). As such they are
only distantly related to GPR30, the membrane-bound estrogen
receptor (Filardo and Thomas, 2005; Manavathi and Kumar, 2006;
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cluster of the γ-group of rhodopsin-like GPCRs.
Microinjection of XmPRβ antibodies blocks progesterone-induced
maturation, and overexpression of XmPRβ potentiates the effects of
progesterone (Josefsberg Ben-Yehoshua et al., 2007). The ﬁsh homolog
of XmPRβ acts through a pertussis-toxin sensitive Gi protein to inhibit
cAMP production, and so it might be expected that progesterone-
induced X. laevis oocyte maturation would be sensitive to pertussis
toxin as well. However, although pertussis toxin reportedly inhibits or
slows down oocyte maturation in response to progesterone, it does not
affect adenylyl cyclase inhibition by progesterone in isolated oocyte
membranes (Sadler et al., 1984). Also, unlike typical G-protein-mediated
processes in which the rate of GTP exchange onto α subunits increases
with receptor stimulation, applying progesterone to isolated oocyte
membranes decreases the rate of GTP exchange with the membranes
(Sadler and Maller, 1985). These unusual properties raise the possibility
that XmPRβ might act by inhibiting Gs rather than activating Gi.
Consistent with this idea, Jaffe and colleagues demonstrated, ﬁrst
in frog (Gallo et al., 1995), later in mouse (Mehlmann et al., 2002), and
most recently in ﬁsh (Kalinowski et al., 2004), that injection of
neutralizing antibodies against Gsα causes meiosis to resume,
supporting the hypothesis that X. laevis Gsα plays a dominant role in
maintaining meiotic arrest. In contrast, other groups showed evidence
that the Gβγ dimer may be responsible for maintaining X. laevis
oocyte G2 arrest (Lutz et al., 2000) or that both Gsα and Gβγ cooperate
in activating the cAMP signaling pathway (Guzman et al., 2005; Romo
et al., 2002). In either case, these studies suggest the existence of an
activated trimeric G protein(s) in oocytes that maintains high levels of
cAMP and meiotic arrest, raising the possibility that a membrane
bound receptor is required for maintaining the active Gsα and/or Gβγ
subunits at high enough concentrations to sustain a meiotic arrest.
Recent studies have identiﬁed the orphan G-protein coupled
receptor, GPR3, as a Gs activator and an essential mediator of meiotic
arrest in mouse oocytes (Hinckley et al., 2005; Mehlmann, 2005;
Mehlmann et al., 2004). In addition, the related protein GPR12 has also
been proposed to play a critical role in the control of cAMP levels and
in meiotic arrest in rat oocytes (Hinckley et al., 2005). GPR3, GPR12,
and a third orphan receptor, GPR6, are closely related members of the
MECA (melanocortin receptor, EDG receptor, cannabinoid receptor,
adenosine-binding receptor) cluster of the α-group of the rhodopsin
family of GPCRs (Fredriksson et al., 2003). The roles of GPR3 and
GPR12 in mammalian meiotic arrest suggest that somemember of the
GPR3/6/12 family may mediate meiotic arrest in frog oocytes.
Here we have cloned and characterized a X. laevis G-protein
coupled receptor related to GPR3, GPR6, and GPR12. Although its
closest human relative is GPR12, it is not the X. laevis GPR12 homolog,
but rather a novel G-protein coupled receptor of a family found in ﬁsh
and amphibians, but not mammals. We term this protein GPRx and
present functional evidence that GPRx is important for maintenance
of meiotic arrest in X. laevis oocytes.
Materials and methods
Database searches
All homology searches were performed using basic local alignment search tool
(BLAST) at the TIGR Unique Gene Indices. The amino acid sequence of the mouse GPR12
(GenBank Accession No. NP20032177), human GPR12 (NP005279), mouse GPR3
(NP032180) and human GPR3 (NP005272) were used to search the X. laevis database
at TIGR. One of the expressed sequence tags (ESTs) displayed (GenBank Accession No.
AW158095) scored the highest sequence identity with the C-terminal end of all four
proteins. This sequence was used to design primers for the ampliﬁcation of X. laevis
GPR12 relatives.
Cloning and sequencing
The method of rapid ampliﬁcation of cDNA ends (RACE) (Invitrogen catalog no.
18374-058) was used to amplify the 5′-end of AW158095. Total RNA was isolated from
stage VI oocytes using the RNeasy Midi kit (Qiagen catalog no. 75144), and 5′-RACE wasperformed according to themanufacture's protocol using the primers GSP1 (5′-ATC TGC
TAC CAG CGA ATA AAC-3′), GSP2 (5′-AAA GGT GCC CAG TAT AAG GGA-3′) and nested
GSP (5′-GTT GAA ACC CCC TTC CTG GTA-3′). The 5′-RACE products were run on a 1%
agarose gel containing 0.1 μg/ml ethidium bromide. A single band was puriﬁed using
the QIAquick Gel Extraction kit (Qiagen catalog no. 28704) and sent for sequencing.
Finally, the whole coding region of this clone, termed GPRx, FLAG epitope-tagged at the
C-terminus, was ampliﬁed from stage VI oocyte double stranded cDNA by ThermoScript
RT-PCR System (Invitrogen catalog no. 11146-040), subcloned into pCS107 to allow
production of synthetic mRNAs in vitro, and sequenced. The ﬁnal set of primers used
were: 5′-CGC CGC GGATCC ATG CTT CAC CAG CCT GCAGTC-3′ and 5′-CGG CGG GAATTC
ACT CTT GTC GTC ATC GTC CTT GTA GTC TAC GTC ACT GGA AGT TCT-3′. These primers
include BamHI and EcoRI restrictions sites.
Analysis of protein sequence
Transmembrane segments were identiﬁed by the hidden Markov model for
topology prediction (HMMTOP) method (Tusnady and Simon, 1998; Tusnady and
Simon, 2001). Alignments of protein sequences were performed using Clustal Qt and
phylogenetic trees were derived from these alignments using Njplot.
RNA extraction and QPCR
RNA was extracted using RNeasy Maxi kit (Qiagen catalog no. 75162), treated with
DNAse I (Sigma catalog no. AMP-D1) and reverse transcribed with the ThermoScript
RT-PCR System (Invitrogen catalog no. 11146-040), using 1 μg of RNA from X. laevis
oocytes, embryos, or tissues. Quantitative RT-PCR reactionswere performed in triplicate
using one tenth of the cDNA reaction, 100 nM primers, and 2.5 μl of 20× EvaGreen
(Biotium, Hayward, CA) in a 50 μl reaction. Primer pairs were as follows: GPRx 5′TCT
CTA CAA TGC CCT CAC C-3′ and 5′-TCC CTG AAA CAG TTC CAC C-3′; L32 5′-AAA TTG AAG
GAG TCT ATG CTC G-3′ and 5′-TCA CCT TTC CCC AGA TCA C-3′. Reactions were
performed on a DNA Engine Opticon 2 Real-Time PCR Detection System using the
following cycling conditions: 94 °C 30 s, 55 °C 30 s, 72 °C 45 s for 40 cycles. PCR product
speciﬁcity was veriﬁed with a melting curve and by running on agarose gel electro-
phoresis. Relative expression analyses were performed using the ΔΔCT method
normalized to X. laevis ribosomal protein L32 mRNA. Tissues were normalized to
ovary, oocytes and embryos to stage 6 oocytes treated with progesterone.
Oocytes
Pieces of ovary were removed from anesthetized female X. laevis. Stage VI oocytes
were isolated by treatment with 0.2% collagenase (Sigma catalog no. C-0130) in
modiﬁed Barth's solution (MBS) without Ca2+ (88 mM NaCl, 1 mM KCl, 1 mM MgSO4,
2.5 mM NaHCO3, and 5 mM HEPES pH 7.8) for 1–1.5 h at room temperature.
Collagenase-treated oocytes were washed ﬁve times with MBS and three times with
OR2 solution (82.5 mMNaCl, 2.5 mMKCl, 1 mM CaCl2,1 mMMgCl2, 1 mMNa2HPO4, and
5 mM HEPES pH 7.8), and were kept overnight at 16 °C on agarose dishes in a medium
composed of 50% Leibovitz's L-15 medium with L-glutamine (GIBCO catalog no. 11417-
064)), 15 mM HEPES pH 7.9, 50 μg/ml gentamicin (Sigma catalog no. G1272), and 5%
fetal bovine serum (GIBCO catalog no. 26140-079). Defolliculated stage VI oocytes were
manually selected, and injections were performed.
Morpholinos and mRNA injections
A morpholino antisense oligo targeted to GPRx was designed by Gene Tools, LLC
(Philomath, OR, www.gene-tools.com) based on the cDNA sequence of X. laevis GPRx.
The morpholino sequence against the GPRx mRNA is 5′-AGGCTGGTGAAGCATTGCTA-
TATGC-3′. The standard control morpholino (5′-CCTCTTACCTCAgTTACAATTTATA-3′)
was also purchased from Gene Tools, LLC. All morpholinos were dissolved in RNase-free
water at 1.0 mM stock concentration. GPRx mRNA was generated through in vitro
transcription using linearized plasmid DNA as template and the mMESSAGE
mMACHINE kit (Ambion catalog no. 1340) with SP6 polymerase. GPRx mRNA was
diluted to 1 μg/μl stock concentration. Subsequent injections were carried out in OR2
solution using a nanoinjector (Drummond Scientiﬁc). Rescue experiments were
performed by co-injecting the morpholino with the mRNA. After 24–36 h, maturation
was induced with 1.5 μM progesterone in OR2 solution and GVBD was scored by the
appearance of a white spot in the animal pole of the oocyte.
Oocyte lysis
Oocytes were lysed by pipetting up and down in 10 μl/oocyte lysis buffer (0.25 M
sucrose, 100 mM NaCl, 2.5 mM MgCl2, 20 mM HEPES, pH 7.2) containing 10 mM EDTA,
protease inhibitors (10 μg/ml leupeptin, 10 μg/ml pepstatin, 10 μg/ml aprotinin, 1 mM
PMSF), and phosphatase inhibitors (50 mM 2-glycerophosphate, 1 mM Na3VO4, 2 mM
NaF). Samples were clariﬁed by centrifugation for 5min in a Beckman Emicrocentrifuge
(Fullerton, CA) with a right-angle rotor. The clariﬁed supernatant was removed and
mixed with an equal volume of 2× Laemmli sample buffer for subsequent SDS-PAGE.
Oocyte membrane preparation
Oocytes (typically 30–50) were homogenized with a Dounce homogenizer (pestle
A,15 strokes) in 10 μl/oocytemembrane buffer (83mMNaCl,1mMMgCl2,10mMHepes
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1 mM Na3VO4), and protease inhibitors (10 μg/ml aprotinin, 10 μg/ml leupeptin, 10 μg/
ml chymostatin, 10 μg/ml pepstatin, and 1 mM PMSF) at 4 °C. The homogenate was
centrifuged at 1000×g for 10 min, and the supernatant was removed and centrifuged
again at 1000×g. This supernatant was then centrifuged using a Beckman/Coulter TLA-
100.3 rotor and Beckman polyallomer microfuge tubes at 95,000 rpm for 30 min or at
14,000 rpm for 60 min using a Tomy MTX-150 refrigerated microcentrifuge in standard
microcentrifuge tubes. The supernatant was saved and the membrane pellet was
resuspended in membrane buffer (10 μl/oocyte). The suspension was centrifuged one
more time at 95,000 rpm for 30 min or 14,000 rpm for 60 min, and this ﬁnal pellet was
resuspended in buffer (50 mM Tris pH 6.8, and 4% SDS). Protein concentration was
determined by the Bradford method and samples were stored at −80 °C until needed.
Antibody production
Peptide antibodies directed against the N-terminus of GPRx were raised in rabbits
using the following peptide conjugated to keyhole limpet hemocyanin and ovalbumin
for immunization: Ac-HLHNDSSGRIFHHQHDPWC-amide. Peptide synthesis, immuni-
zations, characterization with ELISA method, and afﬁnity puriﬁcation of the antibodies
were performed by Quality Controlled Biochemicals (Hopkinton, MA).
Western blotting
Samples of oocyte extracts andmembrane fractions were run on SDS-PAGE gels and
transferred to poly(vinylidene diﬂuoride) (PVDF) membranes (Millipore catalog no.
IPVH00010), which were then blocked with 3% non-fat milk in Tris-buffered saline
(150 mM NaCl and 20 mM Tris; pH 7.6) and incubated for 1 h with a 1:1000 dilution of
one of the following primary antibodies: anti-MAPK (DC3, raised in our laboratory),
anti-GPRx, or anti-FLAG M2 (SIGMA catalog no. F3165). Blots were washed three times
with Tris-buffered saline plus 0.1% Tween-20 and probed with horseradish peroxidase
(HRP)-conjugated secondary antibody (Zymed catalog no. 81-6120 or 81-6720) for 1 h.
The signal was detected by Immun-Star-HRP Chemiluminescent system (Bio-Rad
catalog no. 170-5041).
Deglycosylation
Deglycosylation of GPRx with endoglycosidase H (Endo H) (New England BioLabs
catalog no. P0702L) and/or N-glycosidase F (PNGase F) (New England BioLabs catalog
no. P0704S) was carried out according to the manufacturer's protocol. The products of
the reaction were separated by SDS-PAGE and western blotting with anti-GPRx.
In vitro translation
In vitro translation from GPRx mRNA, or coupled transcription/translation from an
SP6 promoter and GPRx cDNA, were carried out with a TnT rabbit reticulocyte lysate
kit (Promega catalog no. L4600). Alternatively, we used X. laevis egg extracts (Smythe
and Newport, 1991) for the in vitro translation of GPRx, as described (Matthews and
Colman, 1991).
cAMP measurements
We determined cAMP by using Assay Designs' cyclic AMP Complete Enzyme
Immunometric Assay kit (Assay Designs catalog no. 900-163). We lysed 10 oocytes, by
forcing them through pipette tips, in 250 μl of ice-cold 95% ethanol. Extracts were
centrifuged at 15,000×g for 15 min at 4 °C. The supernatants were transferred to new
tubes and dried under vacuum. The residuewas dissolved, subjected to acetylation, and
cAMP was measured according to the kit's provided protocol.
Results
Cloning and sequence analysis of X. laevis GPRx
To ﬁnd a X. laevis homolog of mammalian GPR3 or GPR12 we
searched the X. laevis database at TIGR Unique Gene Indices and
identiﬁed the EST AW158095 as the best candidate for X. laevis GPR12.
The EST was ampliﬁed from a X. laevis cDNA pool by 5′ RACE (see
Materials and methods) and was subcloned into pCS107. The cDNA
clone obtained was 1434 nucleotides (nt) in length, including a 5′
untranslated region (UTR) of 331 nt and 3′-UTR of 63 nt excluding the
poly(A) tail (accession number 895822). The ORF encodes a predicted
protein of 340 residues with a molecular weight of 37,477. There are
three in frame stop codons upstream of this ORF. The predicted
protein product contains the seven transmembrane (TM) regions
characteristic of G-protein coupled receptors (Fig. 1A) (Tusnady and
Simon, 1998; Tusnady and Simon, 2001). There is no obvious signal
peptide or signal peptidase cleavage site at the N-terminus of theprotein; as is the case with other GPCRs, the ﬁrst transmembrane
sequence may perform this function.
The closest mouse and human relatives of our predicted protein
were GPR12 proteins, followed by GPR3 and GPR6. Overall, the amino
acid identity was 48% with mouse GPR6, 51% with mouse GPR3, and
63% with mouse GPR12.
We found three Xenopus tropicalis clones close in sequence to our
protein (JGI accession numbers 305630, 404365, and 418969), and
examined the relationships between these proteins, our protein, and
various other vertebrate GPR3/6/12 proteins.We carried out amultiple
sequence alignment of all of the vertebrate GPR3/6/12-like proteins
and constructed a bootstrapped neighbor-joining radial tree (using
Clustal Qt). As shown in Table 1 and Fig. 1B, one X. tropicalis sequence
was the clear homolog of our protein. The other two represent the
X. tropicalis homologs of mouse GPR6 and mouse GPR12 (Fig. 1B).
This indicated that our protein was not the X. laevis GPR12 ortholog,
but rather a member of a distinct group of GPCRs. Consistent with this
identiﬁcation, the zebraﬁsh genome includes both a GPR12 homolog
and two GPCRs more closely related to our protein (Fig. 1B). We
therefore suggest the name GPRx for this new subgroup of GPR3/6/12-
related proteins (Fig. 1B) found, so far, only in amphibians and ﬁsh.
Tissue distribution of GPRx RNA
To assess the tissue distribution of GPRx we performed quantita-
tive RT-PCR on RNA extracted from various tissues. As observed in
Fig. 2A, GPRx is expressed predominantly in brain, with ovary and
testis being the next richest sources. Since we originally cloned GPRx
from stage VI oocyte cDNA, we wanted to assess if GPRx expression
was regulated throughout oogenesis. We treated ovaries with
collagenase, manually sorted oocytes from stages I to VI, and
performed qRT-PCR, using the ribosomal protein L32 for normal-
ization (Pierandrei-Amaldi et al., 1982). As observed in Fig. 2B, GPRx
RNA expression was detectable in stage I oocytes and the amount of
GPRx RNA increased several fold during oogenesis. We also fertilized
eggs and assessed GPRx RNA levels (normalized per embryo) at
various stages of embryonic development. The GPRx RNA persisted
until after the midblastula transition (Fig. 2C). Thus GPRx RNA is
expressed at the right time and in the right tissues to make it a
possible regulator of oocyte maturation.
Characterization of the GPRx protein
To begin to characterize the GPRx protein, we translated a C-
terminal Flag-tagged GPRx mRNA in reticulocyte lysates. As shown in
Fig. 3A, the main 35S-labeled band migrated with an apparent
molecular mass of 28 kDa, smaller than the predicted size of the
GPRx protein (37 kDa). This band was recognized by afﬁnity-puriﬁed
antibodies raised against an N-terminal GPRx peptide (Fig. 3A) and
also by Flag antibodies (not shown), indicating that despite its small
apparent molecular mass, it represented the full-length GPRx protein.
As described below, the 28 kDa band did not shift or disappear after
treatment with endoglycosidase H or N-glycosidase F (Fig. 3B and data
not shown). Thus we interpret the p28 GPRx band as representing the
non-glycosylated or minimally glycosylated primary translation
product of GPRx.
However, when microinjected into X. laevis oocytes, the same
GPRx mRNA yielded two major immunoreactive bands at 28 and
35 kDa (Fig. 3B). Similar results were obtained when the GPRx mRNA
was translated in X. laevis egg extracts (Fig. 3C). Our working
hypothesis was that the 35 kDa band represented glycosylated
GPRx. Both bands could be detected in a 95,000 rpm pellet (Fig. 3D)
that contained plasma membrane (Na/K ATPase) and endoplasmic
reticulum (calnexin) markers (not shown). However in some
membrane preparations (not shown) the 28 kDa GPRx band was
underrepresented relative to the 35 kDa band, consistent with the
Fig. 1. GPRx and its relationship to GPR3, GPR6, and GPR12. (A) The nucleotide and deduced amino acid sequence of Xenopus laevis GPRx. The GenBank accession number is 895822.
Nucleotides are numbered to the right and amino acids to the left. Lowercase letters indicate untranslated regions. The predicted transmembrane domains are shaded and are
numbered with Roman numerals. (B) Radial tree obtained using ClustalQt and Njplot showing the relationships between the GPR3, GPR6, GPR12, and GPRx proteins. This unrooted
neighbor-joining tree was constructed by bootstrapping using 1000 seeds. Because one sequence (chicken GPR6) contained a long N-terminal extension absent from the other GPR
sequences, positions with gaps were ignored in constructing the tree.
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associated. Treatment of themembrane pellet with endoglycosidase H
caused the 35 kDa band to disappear and the 28 kDa band to increasein intensity (Fig. 3B, lane 2), without affecting the intensities of two
higher molecular weight (50 and 60 kDa) bands. Similar results were
obtained with N-glycosidase F (not shown). Thus the 35 kDa band
Table 1
G-protein coupled receptors related to GPRx
Protein Species Source Accession
number
NCBI/JGI deﬁnition
GPR3 Human NCBI NP_005272 G protein-coupled receptor 3
Mouse NCBI NP_032180 G protein-coupled receptor 3
Cow NCBI XP_612644 Similar to G protein-coupled receptor
GPR3
Opossum NCBI XP_001371085 Similar to G protein-coupled receptor
GPR3
GPR6 Human NCBI NP_005275 G protein-coupled receptor 6
Mouse NCBI AAI11862 G protein-coupled receptor 6
Cow NCBI NP_001093777 Hypothetical protein LOC50666
Opossum NCBI XP_001368592 Similar to putative G protein-coupled
receptor
Chicken NCBI XP_426182 Hypothetical protein
Fugu JGI 572864 –
X.
tropicalis
JGI 418969 Putative ortholog of probable
G-protein coupled receptor GPR6
GPR12 Human NCBI AAH67449 GPR12 protein
Mouse NCBI XP_601035 G-protein coupled receptor 12
Cow NCBI XP_601035 Similar to putative GPR12 G protein
coupled-receptor
Opossum NCBI XP_001366959 Similar to putative GPR12 G protein
coupled-receptor
Platypus NCBI XP_001519402 Similar to GPR12 protein
Chicken NCBI XP_425637 Similar to GPR12 protein
X.
tropicalis
JGI 404365 Putative ortholog of probable
G-protein coupled receptor GPR12
Danio rerio NCBI XP_693970 Hypothetical protein
Fugu JGI 588755 –




GPRx-1 Danio rerio NCBI XP_693580 Hypothetical protein
GPRx-2 Danio rerio NCBI XP_001339092 Hypothetical protein
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appears to be a more highly glycosylated form of the 28 kDa band.
A faint endogenous 28 kDa GPRx band was also detected in oocyte
membranes (Fig. 3B, lanes 3 and 4; Fig. 3D, left; Fig. 4A). However, the
35 kDa GPRx bandwas not detected (Figs. 3B, D), raising the possibility
that it is either extremely scarce or it is processed further in oocytes toFig. 2. GPRx RNA expression. (A) Quantitative RT-PCR analysis of GPRx expression in Xenop
transcripts quantiﬁed by RT-PCR. (B) Quantitative RT-PCR analysis of GPRx expression throug
L32 mRNA. (C) Quantitative RT-PCR analysis of GPRx expression during embryogenesis. GPRa form with a different molecular weight. Consistent with the latter
possibility, two other bands were seen in GPRx immunoblots of oocyte
membranes, at 50 kDa and 60 kDa (Figs. 3B, D). Both the p50 and p60
bands were present in 95,000 rpm membrane pellets, whereas only
the p50 band was detected in lower speed pellets (Fig. 3D, right, and
E). To further test the identities of the 50 and 60 kDa bands, we
compared immunoblots from control oocytes and oocytes micro-
injected with a GPRx morpholino oligonucleotide. The 28 and 50 kDa
bands were greatly diminished in oocytes injected with a GPRx
morpholino oligonucleotide (Fig. 3D, left; E; see also Fig. 4A), but the
60 kDa was unaffected. A number of bands were seen in the
supernatant, but none disappeared from the morpholino-injected
sample (Fig. 3D). We repeated the analysis using a lower speed
(14,000×g) centrifugation and found one main band in the pellet, the
50 kDa band, which, again, was decreased in intensity in oocytes
injection with GPRx morpholinos (Fig. 3E). This indicates that p28
GPRx and the p50 band are likely to be GPRx-related, whereas the p60
band is likely to be a cross-reacting protein. As shown in Fig. 3E, p50
levels increased during oogenesis, plateauing around stages III–IV, and
remained roughly constant during oocyte maturation.
Other members of the GPR3/6/12 family have been shown to
increase intracellular cAMP concentrations (Freudzon et al., 2005;
Hinckley et al., 2005; Mehlmann et al., 2004; Norris et al., 2007;
Tanaka et al., 2007; Uhlenbrock et al., 2002). We were therefore
interested in determining if the same was true of GPRx. As shown in
Fig. 3F, the expression of GPRx in oocytes increased cAMP levels by
approximately 60%. Under these conditions the receptor is estimated
to be overexpressed ∼2–4-fold (e.g. Fig. 3B), consistent with the
hypothesis that GPRx is not the only GPCR contributing to the oocyte's
cAMP levels. Under conditions where GPRx morpholinos decreased
protein levels substantially (Figs. 3D, E), there was no measurable
change in cAMP levels (b9%; Fig. 3F), again consistent with the
hypothesis that GPRx is not solely responsible for cAMP production.
Morpholino injections accelerate progesterone-induced oocyte
maturation
Although we saw no obvious decrease in cAMP levels in GPRx-
morpholino-injected oocytes, the magnitude of cAMP decreaseus laevis tissues. The GPRx levels were normalized to ribosomal protein L32, with both
h oogenesis. As in panel A, the GPRx was normalized to Xenopus laevis ribosomal protein
x was normalized per embryo.
Fig. 3. Characterization of the GPRx protein. (A) In vitro transcription and translation of GPRx in rabbit reticulocyte lysates. The GPRx cDNA (1 μg per reaction) was transcribed with
SP6-RNA polymerase and translated in the presence of [35S]methionine. The reactions were analyzed by SDS PAGE followed by autoradiography and GPRx immunoblotting. (B)
Ectopic expression of GPRx in Xenopus laevis oocytes. Oocytes were injected with GPRx mRNA (32 ng/oocyte) and allowed to express for 24 h. Membranes were prepared by
centrifugation at 12,000 rpm and treated with or without endoglycosidase H (Endo H, 500 U per reaction) for 1 h. Proteins were analyzed by GPRx immunoblotting. (C) In vitro
translation of GPRx in Xenopus laevis egg extracts. GPRx mRNA (1 μg) was translated in the presence of [35S]methionine. Samples of the whole reaction mixture (“Extract”) or
membrane fractions (“Membrane”) were analyzed by autoradiography and GPRx immunoblotting. (D) Endogenous oocyte proteins recognized by the GPRx antibody. Membranes
were prepared by 95,000 rpm centrifugation. Lane 1, membranes from stage VI oocytes; lane 2, membranes from stage VI oocytes treated with 5 μM progesterone to induce
maturation; lane 3, membranes from stage VI oocytes injected with 64 ng morpholinos; lane 4, supernatant from stage VI oocytes; lane 5, supernatant from stage VI oocytes treated
with 5 μMprogesterone to inducematuration; lane 6, supernatant from stage VI oocytes injectedwith 64 ngmorpholinos. The inset shows a section of the same blot with the contrast
and brightness adjusted to make the faint p28 band more apparent. (E) Accumulation of the p50 protein during oogenesis. Membranes were prepared by 14,000 rpm centrifugation.
From lane 1 to 6, all stages oocytes; lane 7, membranes from stage VI oocytes treated with 5 μMprogesterone to induce maturation; lane 8, membranes from stage VI oocytes injected
with 64 ng morpholinos. (F) cAMP levels in oocytes microinjected with GPRxmRNA (23 ng/oocyte), GPRx morpholino oligonucleotides 51 ng/oocyte), or control morpholinos (50 ng/
oocyte). Data are shown as means±S.E. from 20 experiments and are expressed relative to uninjected controls. The difference between the cAMP levels in the GPRx mRNA-injected
oocytes and uninjected controls was statistically signiﬁcant by the Student's t-test (P=0.0009). The difference between the cAMP levels in the GPRx morpholino-injected oocytes and
the control morpholino-injected oocytes was 3±8.6%, which was not signiﬁcant.
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Schorderet-Slatkine et al., 1982), raising the possibility that the
contribution of GPRx towards maintaining cAMP levels may still be
functionally signiﬁcant. To explore this further, we examined the
kinetics of oocyte maturation in GPRx-morpholino-injected oocytes.
The morpholinos were again effective in decreasing the intensity of
both the p50 band and p28 GPRx (Fig. 4A, with membranes prepared
at 95,000×g to allow detection of both bands), whereas control
morpholinos had little or no effect (Fig. 4A). Morpholino-injected
oocytes did not spontaneously mature, even 6 days post-injection (not
shown), but progesterone-treated morpholino-injected oocytes
underwent GVBD approximately 30 min earlier than progesterone-
treated uninjected and control-injected oocytes did (Fig. 4B). The
morpholino-injected oocytes also showed earlier activation of p42
MAPK, a biochemical correlate of GVBD, compared to uninjected and
control-injected oocytes (Fig. 4C). These results demonstrate that the
reduction of GPRx accelerates progesterone-induced oocyte activa-
tion, and suggest that GPRx is a negative regulator of oocyte
maturation, either through its contribution to maintaining cAMP or
through some other as yet unidentiﬁed signaling pathway.Injection of GPRx mRNA blocks progesterone-induced oocyte activation
To determine whether overexpression of p28 and p35 GPRx can
disrupt maturation, we injected oocytes with different concentrations
of GPRx mRNA and scored for GVBD after 8 h of progesterone
treatment. We found that oocytes injected with concentrations of
mRNA higher than 0.5 ng failed to undergo GVBD and activation of
MAPK (Fig. 5A). mRNA concentrations lower than 0.5 ng of mRNA
blocked maturation in a fraction of the oocytes (Fig. 5A). This is
consistent with the hypothesis that GPRx normally functions as an
inhibitor of maturation.
To test the speciﬁcity of this overexpression effect, we co-
injected 70 ng of morpholinos with different concentrations of
GPRx mRNA. As shown in Fig. 5B, the GPRx morpholinos blocked
the effect of GPRx mRNA on maturation and p42 MAPK activation.
This rescue shows that the suppression of maturation is not due
to general toxicity of the GPRx mRNA, but rather depends upon
the production of GPRx protein. The rescue also serves to
corroborate the speciﬁcity of the morpholino effect, since the
morpholino's ability to accelerate progesterone-induced maturation
Fig. 4. Effects of GPRx morpholino oligonucleotides on progesterone-induced maturation. (A) Immunoblot of Xenopus laevis oocyte membranes showing knock-down of endogenous
GPRx. Total protein is 20 μg/lane. (B) Modest acceleration of GVBD in response to injection of morpholinos against GPRx into Xenopus laevis oocytes. Oocytes were injected with 50 to
130 ng of control morpholinos or GPRx morpholinos, incubated 24 h, and scored for GVBD at various time after 1.5 μM progesterone stimulation. Data are taken from ﬁve separate
experiments. For each experiment we deﬁned t=0 as the timewhen 50% of the control oocytes had matured. (C) Modest acceleration of p42 MAPK activation in morpholino-injected
oocytes. The data shown are from one of the ﬁve experiments included in panel B, with 10 randomly-selected oocytes taken per time point.
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(Fig. 5B).
Discussion
Here we report the cloning and characterization of GPRx, a new
member of the GPR3/6/12 family of G-protein coupled receptors. The
closest human homolog of GPRx is GPR12. However, GPRx is not the X.
laevis ortholog of GPR12, but rather a member of a separate branch of
the GPR3/6/12-family tree (Fig. 1). GPRx orthologs are present in X.
laevis, X. tropicalis, and Danio rerio (zebraﬁsh). However no GPRx
homologs have been cloned from chicken, mice, or humans; so far the
GPRx subgroup of GPR3/6/12 receptors has only been found in
amphibians and ﬁsh. GPRx is expressed at highest levels in brain, but
is also expressed at relatively high levels in ovary and testis (Fig. 2A). The
GPRx RNA increases in abundance during oogenesis, plateauing at
around stage IV, and ismaintained until after themidblastula transition.
We have detected at least two and possibly three forms of the GPRx
protein. The ﬁrst is p28 GPRx. This is the main form produced by in
vitro translation in reticulocyte lysates (Fig. 3A) and X. laevis egg
lysates (Fig. 3C), and is detected in X. laevis oocytes as well (Figs. 3B, D
and 4A). p28 GPRx probably represents the full-length, hypoglycosy-
lated or non-glycosylated form of the protein. The second form of
GPRx is p35 GPRx, which is detected after in vitro translation of GPRx
in X. laevis egg lysates or expression of GPRx in intact oocytes (Figs. 3B,
C). p35 GPRx represents a more heavily glycosylated form of p28 GPRx
(Fig. 3B). The third possible form of GPRx is p50, a protein present in X.
laevis membrane preparations that is recognized by afﬁnity-puriﬁed
GPRx antibodies and knocked down by GPRxmorpholinos (Figs. 3B, D,
E and 4A). One possibility is that p50 represents the most fully
glycosylated form of GPRx, and that it is difﬁcult to get this full
processing in either X. laevis extracts or in oocytes during over-
expression. However, neither endoglycosidase H (Fig. 3B, lanes 3 and
4) nor N-glycosidase F (not shown) caused the p50 band to disappear
or shift to a lower molecular weight, indicating that p50 either is not
heavily glycosylated or is glycosidase-resistant. A second possibility isthat p50 represents a GPRx dimer. However, variations in the buffer
used for preparing gel samples (e.g. 2.3% to 10% SDS; boiled vs. 37 °C
vs. 4 °C samples) did not affect the yield of p50 (data not shown).
Another possibility is that p50 is GPRx translated from an alternatively
spliced transcript, or that the pseudo-tetraploid X. laevis possesses
both a long and a short GPRx gene. Consistent with either of these
possibilities, the cDNA reported for chicken GPR6 encodes a protein
that is about twice as big (675 aa) as the other known vertebrate
GPR3/6/12/x family members (330–340 aa). Finally, it is possible that
p50 is only distantly related to GPRx and that its knockdown with
GPRx morpholinos was an off-target effect.
The expression of GPRx in fully-grown oocytes suggests some role
in oocyte maturation. Its relatives GPR12 and GPR3 have been shown
to contribute to the maintenance of meiotic arrest in mouse and rat
oocytes (Freudzon et al., 2005; Hinckley et al., 2005;Mehlmann, 2005;
Mehlmann et al., 2004), and our studies indicate a similar role for
GPRx in X. laevis oocytes. Like GPR3/6/12, GPRx expression increases
cAMP levels (Fig. 3F). Moreover, knocking-down GPRx expression
accelerates progesterone-induced maturation, and overexpression of
GPRx inhibits progesterone-induced maturation (Figs. 4 and 5). One
caveat to this ﬁnding is that when GPRx is overexpressed in oocytes, a
35 kDa form that is not detectable in non-injected oocytes is produced
(Fig. 3B). This p35 GPRx may represent a partially glycosylated form,
with p50 representing the natural, fully processed GPRx protein, or it
may represent a fully glycosylated form that is simply too scarce to
detect in uninjected oocytes. Note, however, that the exact glycosyla-
tion state of GPRx may not be critical for the tonic activation of
adenylyl cyclase.
Our current view of the initial events in progesterone-induced
oocyte maturation is shown in Fig. 6. GPRx helps maintain adenylate
cyclase activation and opposes oocyte maturation. Some other
progesterone-responsive protein, with XmPRβ being the most
plausible candidate, then triggers the change in balance between
cAMP synthesis and destruction that brings about oocyte maturation.
Several important questions remain unanswered. It seems likely
that other GPCRs contribute to G2 arrest in X. laevis oocytes, but it is
Fig. 6. Schematic view of the role of GPRx in maintaining meiotic arrest.
Fig. 5. Overexpression of GPRx inhibits maturation and GPRx morpholinos rescue maturation. (A) Overexpression of GPRx inhibits progesterone-induced maturation. Oocytes were
injected with different concentrations of GPRx mRNA, incubated 36 h, and then scored for GVBD after 8 h of treatment with 1.5 μM progesterone. Each bar/lane represents data from
25 oocytes. Results are representative of three independent experiments. (B) Morpholinos rescue progesterone induced maturation in oocytes injected with GPRx mRNA. Oocytes
were injected with different concentrations of GPRx mRNA with or without GPRx morpholinos (70 ng per oocyte), incubated 24 h, and scored for GVBD after 8 h of 1.5 μM
progesterone stimulation. Oocytes were then lysed and subjected to MAPK immunoblotting. Each bar/lane represents data from 25 oocytes.
387D. Ríos-Cardona et al. / Developmental Biology 317 (2008) 380–388not clear what those receptors are. Given that GPR3 orthologs have not
been detected outside of mammals (Fig. 1B), we suspect the relevant
protein(s) may be GPR6 and/or GPR12. However, the X. laevis GPR6
and GPR12 genes have not yet been identiﬁed, although sequences for
both are available from the closely related species X. tropicalis (Table
1). Oocytes also express numerous G-protein coupled receptors
outside of the GPR3/6/12/x subfamily (Hinckley et al., 2005). The
roles of these receptors in oocyte physiology are largely unknown; it
seems plausible that some contribute to the regulation of cAMP levels
and the establishment of the G2 arrest state.
In addition, it is not know whether GPRx's activity is modulated.
One possibility is that GPRx may be regulated by progesterone or
androgens, as is true of XmPRβ, by ligands like sphingosine-1-
phosphate that have been implicated as potential agonists at other
GPR3/6/12 family receptors, or by other unidentiﬁed ligands. The
answers to these questions may help us to better understand the non-
genomic effects of steroid hormones and the biochemical physiology
of oocyte maturation.
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